APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mono Hepatitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mono Hepatitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchMono Hepatitis Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Mono Hepatitis Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Mono Hepatitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mono Hepatitis Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Mono Hepatitis Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Mono Hepatitis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mono Hepatitis Vaccine include Sanofi, Merck, GSK, Zhejiang Pukang, Sinovac, Serum Institute, NCPC, LG Life Sciences and KM Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mono Hepatitis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mono Hepatitis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mono Hepatitis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mono Hepatitis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mono Hepatitis Vaccine Segment by Company

Sanofi

Merck

GSK

Zhejiang Pukang

Sinovac

Serum Institute

NCPC

LG Life Sciences

KM Biologics

IMBCA

Hissen

Dynavax

ChangSheng

Bio Kangtai

Mono Hepatitis Vaccine Segment by Type

Hepatitis A Vaccines

Hepatitis B Vaccines

Mono Hepatitis Vaccine Segment by Application

Children

Adult

Mono Hepatitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mono Hepatitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mono Hepatitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mono Hepatitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mono Hepatitis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mono Hepatitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mono Hepatitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mono Hepatitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mono Hepatitis Vaccine Industry Trends Table 2. Mono Hepatitis Vaccine Industry Drivers Table 3. Mono Hepatitis Vaccine Industry Opportunities and Challenges Table 4. Mono Hepatitis Vaccine Industry Restraints Table 5. Global Mono Hepatitis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mono Hepatitis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mono Hepatitis Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Mono Hepatitis Vaccine Sales Market Share by Manufacturers Table 9. Global Mono Hepatitis Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mono Hepatitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mono Hepatitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mono Hepatitis Vaccine Manufacturers, Product Type & Application Table 13. Global Mono Hepatitis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mono Hepatitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hepatitis A Vaccines Table 17. Major Manufacturers of Hepatitis B Vaccines Table 18. Global Mono Hepatitis Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Mono Hepatitis Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Mono Hepatitis Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Mono Hepatitis Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Mono Hepatitis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Mono Hepatitis Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Mono Hepatitis Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Mono Hepatitis Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Mono Hepatitis Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Children Table 29. Major Manufacturers of Adult Table 30. Global Mono Hepatitis Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Mono Hepatitis Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Mono Hepatitis Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Mono Hepatitis Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Mono Hepatitis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Mono Hepatitis Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Mono Hepatitis Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Mono Hepatitis Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Mono Hepatitis Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Mono Hepatitis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Mono Hepatitis Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Mono Hepatitis Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Mono Hepatitis Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Mono Hepatitis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Mono Hepatitis Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Mono Hepatitis Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Mono Hepatitis Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Mono Hepatitis Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Mono Hepatitis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Mono Hepatitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Mono Hepatitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Mono Hepatitis Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Mono Hepatitis Vaccine Revenue Market Share by Region (2027-2032) Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sanofi Mono Hepatitis Vaccine Product Portfolio Table 66. Sanofi Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck Mono Hepatitis Vaccine Product Portfolio Table 71. Merck Recent Development Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GSK Mono Hepatitis Vaccine Product Portfolio Table 76. GSK Recent Development Table 77. Zhejiang Pukang Company Information Table 78. Zhejiang Pukang Business Overview Table 79. Zhejiang Pukang Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Zhejiang Pukang Mono Hepatitis Vaccine Product Portfolio Table 81. Zhejiang Pukang Recent Development Table 82. Sinovac Company Information Table 83. Sinovac Business Overview Table 84. Sinovac Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sinovac Mono Hepatitis Vaccine Product Portfolio Table 86. Sinovac Recent Development Table 87. Serum Institute Company Information Table 88. Serum Institute Business Overview Table 89. Serum Institute Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Serum Institute Mono Hepatitis Vaccine Product Portfolio Table 91. Serum Institute Recent Development Table 92. NCPC Company Information Table 93. NCPC Business Overview Table 94. NCPC Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. NCPC Mono Hepatitis Vaccine Product Portfolio Table 96. NCPC Recent Development Table 97. LG Life Sciences Company Information Table 98. LG Life Sciences Business Overview Table 99. LG Life Sciences Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. LG Life Sciences Mono Hepatitis Vaccine Product Portfolio Table 101. LG Life Sciences Recent Development Table 102. KM Biologics Company Information Table 103. KM Biologics Business Overview Table 104. KM Biologics Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. KM Biologics Mono Hepatitis Vaccine Product Portfolio Table 106. KM Biologics Recent Development Table 107. IMBCA Company Information Table 108. IMBCA Business Overview Table 109. IMBCA Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. IMBCA Mono Hepatitis Vaccine Product Portfolio Table 111. IMBCA Recent Development Table 112. Hissen Company Information Table 113. Hissen Business Overview Table 114. Hissen Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Hissen Mono Hepatitis Vaccine Product Portfolio Table 116. Hissen Recent Development Table 117. Dynavax Company Information Table 118. Dynavax Business Overview Table 119. Dynavax Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Dynavax Mono Hepatitis Vaccine Product Portfolio Table 121. Dynavax Recent Development Table 122. ChangSheng Company Information Table 123. ChangSheng Business Overview Table 124. ChangSheng Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. ChangSheng Mono Hepatitis Vaccine Product Portfolio Table 126. ChangSheng Recent Development Table 127. Bio Kangtai Company Information Table 128. Bio Kangtai Business Overview Table 129. Bio Kangtai Mono Hepatitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Bio Kangtai Mono Hepatitis Vaccine Product Portfolio Table 131. Bio Kangtai Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Mono Hepatitis Vaccine Distributors List Table 135. Mono Hepatitis Vaccine Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Mono Hepatitis Vaccine Product Image Figure 2. Global Mono Hepatitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mono Hepatitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mono Hepatitis Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Mono Hepatitis Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mono Hepatitis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hepatitis A Vaccines Image Figure 9. Hepatitis B Vaccines Image Figure 10. Global Mono Hepatitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Mono Hepatitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Mono Hepatitis Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Mono Hepatitis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Mono Hepatitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Mono Hepatitis Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Children Image Figure 17. Adult Image Figure 18. Global Mono Hepatitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Mono Hepatitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Mono Hepatitis Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Mono Hepatitis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Mono Hepatitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Mono Hepatitis Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Mono Hepatitis Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Mono Hepatitis Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Mono Hepatitis Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Mono Hepatitis Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Mono Hepatitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Mono Hepatitis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Mono Hepatitis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Mono Hepatitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Mono Hepatitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Mono Hepatitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Mono Hepatitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Mono Hepatitis Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Mono Hepatitis Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis A Vaccines
  • Hepatitis B Vaccines
Applications
  • Children
  • Adult
Companies covered
  • Sanofi
  • Merck
  • GSK
  • Zhejiang Pukang
  • Sinovac
  • Serum Institute
  • NCPC
  • LG Life Sciences
  • KM Biologics
  • IMBCA
  • Hissen
  • Dynavax
  • ChangSheng
  • Bio Kangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mono Hepatitis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mono Hepatitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mono Hepatitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mono Hepatitis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mono Hepatitis Vaccine Market Dynamics
  1. 2.1 Mono Hepatitis Vaccine Industry Trends
  2. 2.2 Mono Hepatitis Vaccine Industry Drivers
  3. 2.3 Mono Hepatitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Mono Hepatitis Vaccine Industry Restraints
3 Mono Hepatitis Vaccine Market by Manufacturers
  1. 3.1 Global Mono Hepatitis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mono Hepatitis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mono Hepatitis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mono Hepatitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mono Hepatitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mono Hepatitis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Mono Hepatitis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mono Hepatitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mono Hepatitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mono Hepatitis Vaccine Tier 1, Tier 2, and Tier 3
4 Mono Hepatitis Vaccine Market by Type
  1. 4.1 Mono Hepatitis Vaccine Type Introduction
  2. 4.1.1 Hepatitis A Vaccines
  3. 4.1.2 Hepatitis B Vaccines
  4. 4.2 Global Mono Hepatitis Vaccine Sales by Type
  5. 4.2.1 Global Mono Hepatitis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mono Hepatitis Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Mono Hepatitis Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Mono Hepatitis Vaccine Revenue by Type
  9. 4.3.1 Global Mono Hepatitis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mono Hepatitis Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Mono Hepatitis Vaccine Revenue Market Share by Type (2021-2032)
5 Mono Hepatitis Vaccine Market by Application
  1. 5.1 Mono Hepatitis Vaccine Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Mono Hepatitis Vaccine Sales by Application
  5. 5.2.1 Global Mono Hepatitis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mono Hepatitis Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Mono Hepatitis Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Mono Hepatitis Vaccine Revenue by Application
  9. 5.3.1 Global Mono Hepatitis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mono Hepatitis Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Mono Hepatitis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Mono Hepatitis Vaccine Sales by Region
  1. 6.1 Global Mono Hepatitis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mono Hepatitis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Mono Hepatitis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Mono Hepatitis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mono Hepatitis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mono Hepatitis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mono Hepatitis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mono Hepatitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mono Hepatitis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mono Hepatitis Vaccine Revenue by Region
  1. 7.1 Global Mono Hepatitis Vaccine Revenue by Region
  2. 7.1.1 Global Mono Hepatitis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mono Hepatitis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Mono Hepatitis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Mono Hepatitis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mono Hepatitis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mono Hepatitis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mono Hepatitis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mono Hepatitis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mono Hepatitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Mono Hepatitis Vaccine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Mono Hepatitis Vaccine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Mono Hepatitis Vaccine Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Zhejiang Pukang
  20. 8.4.1 Zhejiang Pukang Company Information
  21. 8.4.2 Zhejiang Pukang Business Overview
  22. 8.4.3 Zhejiang Pukang Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zhejiang Pukang Mono Hepatitis Vaccine Product Portfolio
  24. 8.4.5 Zhejiang Pukang Recent Developments
  25. 8.5 Sinovac
  26. 8.5.1 Sinovac Company Information
  27. 8.5.2 Sinovac Business Overview
  28. 8.5.3 Sinovac Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sinovac Mono Hepatitis Vaccine Product Portfolio
  30. 8.5.5 Sinovac Recent Developments
  31. 8.6 Serum Institute
  32. 8.6.1 Serum Institute Company Information
  33. 8.6.2 Serum Institute Business Overview
  34. 8.6.3 Serum Institute Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Serum Institute Mono Hepatitis Vaccine Product Portfolio
  36. 8.6.5 Serum Institute Recent Developments
  37. 8.7 NCPC
  38. 8.7.1 NCPC Company Information
  39. 8.7.2 NCPC Business Overview
  40. 8.7.3 NCPC Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NCPC Mono Hepatitis Vaccine Product Portfolio
  42. 8.7.5 NCPC Recent Developments
  43. 8.8 LG Life Sciences
  44. 8.8.1 LG Life Sciences Company Information
  45. 8.8.2 LG Life Sciences Business Overview
  46. 8.8.3 LG Life Sciences Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LG Life Sciences Mono Hepatitis Vaccine Product Portfolio
  48. 8.8.5 LG Life Sciences Recent Developments
  49. 8.9 KM Biologics
  50. 8.9.1 KM Biologics Company Information
  51. 8.9.2 KM Biologics Business Overview
  52. 8.9.3 KM Biologics Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 KM Biologics Mono Hepatitis Vaccine Product Portfolio
  54. 8.9.5 KM Biologics Recent Developments
  55. 8.10 IMBCA
  56. 8.10.1 IMBCA Company Information
  57. 8.10.2 IMBCA Business Overview
  58. 8.10.3 IMBCA Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IMBCA Mono Hepatitis Vaccine Product Portfolio
  60. 8.10.5 IMBCA Recent Developments
  61. 8.11 Hissen
  62. 8.11.1 Hissen Company Information
  63. 8.11.2 Hissen Business Overview
  64. 8.11.3 Hissen Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hissen Mono Hepatitis Vaccine Product Portfolio
  66. 8.11.5 Hissen Recent Developments
  67. 8.12 Dynavax
  68. 8.12.1 Dynavax Company Information
  69. 8.12.2 Dynavax Business Overview
  70. 8.12.3 Dynavax Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dynavax Mono Hepatitis Vaccine Product Portfolio
  72. 8.12.5 Dynavax Recent Developments
  73. 8.13 ChangSheng
  74. 8.13.1 ChangSheng Company Information
  75. 8.13.2 ChangSheng Business Overview
  76. 8.13.3 ChangSheng Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ChangSheng Mono Hepatitis Vaccine Product Portfolio
  78. 8.13.5 ChangSheng Recent Developments
  79. 8.14 Bio Kangtai
  80. 8.14.1 Bio Kangtai Company Information
  81. 8.14.2 Bio Kangtai Business Overview
  82. 8.14.3 Bio Kangtai Mono Hepatitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio Kangtai Mono Hepatitis Vaccine Product Portfolio
  84. 8.14.5 Bio Kangtai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mono Hepatitis Vaccine Value Chain Analysis
  2. 9.1.1 Mono Hepatitis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mono Hepatitis Vaccine Production Mode & Process
  6. 9.2 Mono Hepatitis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mono Hepatitis Vaccine Distributors
  9. 9.2.3 Mono Hepatitis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst